142 related articles for article (PubMed ID: 9498740)
1. Antigen-specific IgG responses from naive human splenocytes: in vitro priming followed by antigen boost in the SCID mouse.
Brams P; Nguyen ML; Chamat S; Royston I; Morrow PR
J Immunol; 1998 Mar; 160(5):2051-8. PubMed ID: 9498740
[TBL] [Abstract][Full Text] [Related]
2. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
3. High titer, prostate specific antigen-specific human IgG production by hu-PBL-SCID mice immunized with antigen-mouse IgG2a complex-pulsed autologous dendritic cells.
Coccia MA; Brams P
J Immunol; 1998 Nov; 161(10):5772-80. PubMed ID: 9820559
[TBL] [Abstract][Full Text] [Related]
4. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
Lum LG; Culbertson NJ
J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
[TBL] [Abstract][Full Text] [Related]
5. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
Daniel PT; Krammer PH
J Immunol; 1994 Jun; 152(12):5624-32. PubMed ID: 7515909
[TBL] [Abstract][Full Text] [Related]
6. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of specific immunoglobulin production in SCID-hu-PBL mice after in vitro priming of human B cells with superantigen.
Mårtensson C; Ifversen P; Borrebaeck CA; Carlsson R
Immunology; 1995 Oct; 86(2):224-30. PubMed ID: 7490122
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific human immunoglobulin production in SCID mice transplanted with human peripheral lymphocytes is dependent on CD4+ CD45RO+ T cells.
Mårtensson C; Kristensson K; Kalliomäki S; Borrebaeck CA; Carlsson R
Immunology; 1994 Oct; 83(2):171-9. PubMed ID: 7835932
[TBL] [Abstract][Full Text] [Related]
9. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies.
Carlsson R; Mårtensson C; Kalliomäki S; Ohlin M; Borrebaeck CA
J Immunol; 1992 Feb; 148(4):1065-71. PubMed ID: 1737926
[TBL] [Abstract][Full Text] [Related]
10. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.
Murphy WJ; Funakoshi S; Fanslow WC; Rager HC; Taub DD; Longo DL
Clin Immunol; 1999 Jan; 90(1):22-7. PubMed ID: 9884349
[TBL] [Abstract][Full Text] [Related]
11. Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes.
Jackson DJ; Kumpel BM
Hum Antibodies; 1997; 8(4):181-8. PubMed ID: 9395920
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
Ponzio NM; Speirs RS
Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
[TBL] [Abstract][Full Text] [Related]
14. [Reconstitution of Hu-SCID mice transplanted with human tonsillar lymphocytes immunized with dengue virus-2 in vitro and its immune response].
Zuo L; Guo H; Zhang C
Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):597-9. PubMed ID: 9275474
[TBL] [Abstract][Full Text] [Related]
15. The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice.
Walker W; Gallagher G
Immunology; 1994 Oct; 83(2):163-70. PubMed ID: 7530687
[TBL] [Abstract][Full Text] [Related]
16. Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells.
Jarman ER; Perschke K; Montermann E; Herz U; Renz H; Knop J; Reske-Kunz AB
J Allergy Clin Immunol; 2000 May; 105(5):967-74. PubMed ID: 10808178
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum: production of human antibodies specific for the MSP-3 protein in the Hu-SPL-SCID mouse.
Bouharoun-Tayoun H; Noun G; Druilhe P; Nakhlé C; Haddad N; Chamat S
Exp Parasitol; 2004; 108(1-2):47-52. PubMed ID: 15491548
[TBL] [Abstract][Full Text] [Related]
18. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
[TBL] [Abstract][Full Text] [Related]
19. Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes.
Boerner P; Lafond R; Lu WZ; Brams P; Royston I
J Immunol; 1991 Jul; 147(1):86-95. PubMed ID: 2051030
[TBL] [Abstract][Full Text] [Related]
20. Evidence for restricted diversity of antigen-specific human antibodies in immunized hu-PBL-SCID mice.
Bazin R; Chevrier MC; Delage R; Lemieux R
Hum Antibodies Hybridomas; 1996; 7(3):129-34. PubMed ID: 9057061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
